Clinical Trials on Herpesviridae-infektiot

Total 13594 results

ModernaTX, Inc.

Completed

Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Completed

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Withdrawn

A Study of mRNA-1647 Cytomegalovirus Vaccine in Liver Transplant Candidates and Recipients

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Enrolling by invitation

A Long-Term Extension Study to Evaluate the Immunogenicity and Safety of Cytomegalovirus (CMV) mRNA-1647 Vaccine

Cytomegalovirus Infection

United States
Emilio Bouza

Completed

CMV Intensive Care Units

CMV Infection

Spain
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.

Cytomegalovirus Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age

Cytomegalovirus Infection

United States, Australia, Canada, France, Belgium, Germany, Israel, Italy, United Kingdom, Spain, Estonia, Finland, Japan
Assistance Publique Hopitaux De Marseille

Completed

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

Cytomegalovirus Infection

France
Washington University School of Medicine
Hoffmann-La Roche

Completed

Study of Prophylactic Vs Preemptive Valganciclovir

Cytomegalovirus Infection

United States
Merck Sharp & Dohme LLC

Completed

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Cytomegalovirus (CMV) Infection

United States, Australia, Colombia, France, Germany, Israel, Japan, Mexico, Poland, Spain, Turkey
AlloVir

Completed

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

CMV Infections

United States
Merck Sharp & Dohme LLC

Completed

Extension of Letermovir (LET) From Day 100 to Day 200 Post-transplant for the Prevention of Cytomegalovirus (CMV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Participants (MK-8228-040)

Cytomegalovirus Infection

United States, France, Germany, Italy, Japan, United Kingdom
University of Nebraska

Completed

Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit

Congenital CMV Infection

United States
Assistance Publique - Hôpitaux de Paris

Completed

Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening (CymeAudit)

Congenital Cytomegalovirus Infection

France
National Institute of Allergy and Infectious Diseases...

Terminated

Asymptomatic Congenital CMV Treatment

Congenital Cytomegalovirus Infection

United States
Institut Pasteur

Completed

Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV (INFECSMELL)

Congenital Cytomegalovirus Infection

France
Affiliated Hospital to Academy of Military Medical...

Unknown

Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China

Viral Infection

China
Jun Zhang

Completed

A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China

Congenital Cytomegalovirus Infection

China
Lower Saxony Center for Nephrology

Completed

Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients

Herpesviridae Infections | Cytomegalovirus Infection | DNA Virus Infection
University Hospital, Bordeaux
Novartis

Completed

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A (EVERCMV)

Transplantation Infection | Cytomegalovirus Infection

France
Assistance Publique - Hôpitaux de Paris

Completed

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir (CYMEVAL2)

Foetuses Infection | Cytomegalovirus (CMV)Infection

France
Shahid Beheshti University of Medical Sciences

Completed

Comparison of Safety and Efficacy of de Novo Everolimus

Cytomegalovirus Infections

Iran, Islamic Republic of
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
VBI Vaccines Inc.
Clinical Trial Data Services, LLC

Completed

Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults

Cytomegalovirus Infections

Canada
Hospital Universitari de Bellvitge
Instituto de Salud Carlos III; Spanish Society of Cardiology

Recruiting

Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response (ELISPOT-TC)

CMV Infection | Heart Transplant Infection

Spain
Fundacio Catalana de Pneumologia
Roche Farma, S.A

Completed

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive (REIVI)

Cytomegalovirus Infections

Spain
Changchun Changsheng Life Science and Technology...
Guangdong Provincial Institute of Biological Products And Materia Medica

Unknown

Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in Children

Chickenpox

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections (LUCY-1)

Cytomegalovirus Infection

France
Maimónides Biomedical Research Institute of Córdoba
Instituto de Salud Carlos III

Completed

Clinical Trial of Efficacy and Safety of the Combination of Reduced Duration Prophylaxis Followed by Immuno-guided Prophylaxis in Lung Transplant Recipients. (CYTOCOR)

Cytomegalovirus Infections | Transplantation Infection

Spain
Fundación Pública Andaluza para la Investigación...
Merck Sharp & Dohme LLC

Completed

Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA (CY-CMV-2020)

CMV Infection

Spain
Ronaldo de Matos Esmeraldo, MD
Novartis Pharmaceuticals

Completed

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Cytomegalovirus Infections | Transplantation Infection

Brazil
University of Alberta

Completed

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Cytomegalovirus Infection

Canada
IRCCS Policlinico S. Matteo

Completed

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection (CHIP)

Cytomegalovirus Infection

Italy
Xiao-Jun Huang

Recruiting

CMV-TCR-T Cells for Refractory CMV Infection After HSCT

Allogeneic Hematopoietic Stem Cell Transplantation | CMV Infection

China
Chinese PLA General Hospital

Recruiting

CMV-TCR-T Cells for CMV Infection After Allogenic HSCT

CMV Infection After Allogenic HSCT

China
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus (ACT-CAT)

Cytomegalovirus Infection | Adenovirus Infection

United States
The Alfred
Cellestis

Completed

Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

HIV Infection | CMV Infection

Australia
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Not yet recruiting

Ganciclovir Resistant Cytomegalovirus Infection in SOT Recipients.

Cytomegalovirus Infections
GlaxoSmithKline
IQVIA, USA

Active, not recruiting

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

Chickenpox

Taiwan, Poland, United States, Estonia, Puerto Rico, Mexico
Karo Pharma AB

Completed

Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device.

Chickenpox

Poland
Changchun Keygen Biological Products Co., Ltd.
Guangdong Provincial Institute of Biological Products And Materia Medica

Completed

Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella Vaccine

Chickenpox

China
National Institute of Allergy and Infectious Diseases...

Completed

Neonatal CMV-Ganciclovir Follow-up Study

Cytomegalovirus Infections

United States
Zhuhai Trinomab Pharmaceutical Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamic Profile of TNM005 in Healthy Adult Subjectsy

Varicella

United States
ModernaTX, Inc.

Completed

Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus Vaccines mRNA-1647 and mRNA-1443 in Healthy Adults

Cytomegalovirus Infection

United States
Hookipa Biotech GmbH
Centre for Vaccinology Ghent - CEVAC

Completed

Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV

Cytomegalovirus Infection

Belgium
GlaxoSmithKline

Completed

Special Drug Use Investigation for VALTREX (Valaciclovir) (Pediatrics Chickenpox)

Varicella
Merck Sharp & Dohme LLC

Completed

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

Varicella
PETHEMA Foundation

Completed

TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant

Cytomegalovirus Infection

Spain
Merck Sharp & Dohme LLC

Completed

A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of CMV Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Cytomegalovirus Infection

China
Chimerix

Completed

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

Cytomegalovirus Infection

United States

3

Subscribe